Regorafenib Promotes Antitumor Immunity via Inhibiting PD-L1 and IDO1 Expression in Melanoma

Authors: Rui-Yan Wu, Peng-Fei Kong, Liang-Ping Xia, Yun Huang, Zhi-Ling Li, Yun-Yun Tang, Yu-Hong Chen, Xuan Li, Ravichandran Senthilkumar, Hai-Liang Zhang, Ting Sun, Xue-Lian Xu, Yan Yu, Jia Mai, Xiao-Dan Peng, Dong Yang, Li-Huan Zhou, Gong-Kan Feng, Rong Deng, Xiao-Feng Zhu

Published: 2019-04-02

DOI: 10.1158/1078-0432.ccr-18-2840

Source: Full article


Abstract

Abstract